Understand Your Genetic
Heart Risk
Before Disease Develops
Gene Coverage
174 Cardiovascular Genes
Turnaround
7–10 Days
Cardiovascular genetic testing reveals inherited mutations that influence heart rhythm, cholesterol metabolism, structural tissue integrity, and overall cardiac function. Move from reactive treatment to predictive prevention.
Precision Heart Diagnostics
Next-generation sequencing evaluates all 174 targets, parsing inherited risk patterns and identifying variants of therapeutic significance.
174
Total Genes
>96%
Read Exons
Deciphering Cardiogenomic
Inheritance Pathways
Cardiovascular genetic testing identifies inherited mutations that influence the structure, rhythm, and function of the heart and blood vessels. Unlike traditional diagnostics, it reveals why cardiovascular disease develops—not just when it clinically appears.
Why Genetics is Transforming Cardiovascular Medicine
Risk Prediction
Identify inherited risk for arrhythmias, cardiomyopathies, and lipid disorders before symptoms appear.
Treatment Precision
Match medications to genetic response patterns (especially anticoagulants, lipid-lowering drugs).
Sudden Cardiac Risk
Detect hidden arrhythmia syndromes before clinically silent sudden events can occur.
Family Protection
Enable cascade testing for relatives at risk of inherited cardiac conditions.
Long-Term Monitoring
Guide lifelong clinical monitoring strategies based on verified genomic risk tiering.
Genetic Conditions Influencing Cardiovascular Health
Our comprehensive sequencing pipeline tests for high-penetrance mutation targets responsible for critical cardiac malfunctions.
Familial Hypercholesterolemia (FH)
Elevated LDL cholesterol from birth leading to high premature coronary artery disease risk.
Long QT Syndrome (LQTS)
Electrical rhythm instability causing cardiac repolarization delays and sudden arrhythmia risk.
Hypertrophic Cardiomyopathy
Inherited thickening of the left ventricular heart muscle predisposing individuals to exercise risks.
Dilated Cardiomyopathy (DCM)
Weakened heart pumping function, enlarged ventricles, and progressive cardiac failure.
Marfan Syndrome
Connective tissue structural vessel weakness creating massive risks for aortic root aneurysms.
Why Physicians Use Cardiovascular Genetic Testing
Diagnostic Clarity
Differentiate inherited vs acquired cardiovascular disease phenotypes.
Treatment Optimization
Improve pharmacology dosing response and anticoagulation accuracy.
Preventive Strategy Design
Enable highly effective clinical intervention decades before symptoms present.
Family Risk Evaluation
Identify high-risk relatives immediately through standard clinical cascade screening.
Advanced Stratification
Support physician monitoring decisions with gene-level risk scoring.
Comprehensive 174-Gene Panel
A clinically curated gene set covering cardiomyopathy mutations, channelopathies, familial lipid disorders, and structural aortopathies.
Cardiovascular Biomarkers
Our comprehensive panel checks for high-penetrance genetic mutations associated with primary inherited lipid profiles, hypertrophic/dilated cardiomyopathies, and electrical channelopathies.
View Full 174-Gene Index
Search individual genes or explore the complete list of cardiovascular targeted genetic elements.
How Cardiovascular Genetic Testing Works
Clinical Evaluation
Family and symptom history review.
Sample Collection
Simple saliva or buccal swab.
NGS Sequencing
Comprehensive 174-gene analysis.
Variant Interpretation
Pathogenic risk classification.
Clinical Reporting
Actionable cardiovascular insights.
Is Cardiovascular Genetic Testing Right for You?
Clinical guidelines recommend testing for patients exhibiting specific family or diagnostic indicator histories.
Diagnostic Indicator
Family history of early heart disease
Diagnostic Indicator
Sudden cardiac events/arrest in relatives
Diagnostic Indicator
Extremely high LDL cholesterol at a young age
Diagnostic Indicator
Unexplained fainting spells or arrhythmias
Diagnostic Indicator
Suspected or diagnosed Cardiomyopathy
Diagnostic Indicator
Early onset hypertension or vascular weakness
Test Specifications
Sample Type
Saliva / Buccal Swab
Turnaround Time
7–10 Business Days
Gene Coverage
174 Curated Exons
Testing Method
Next Generation Sequencing (NGS)
Clinical Reporting
Pathogenic + Likely Pathogenic Variants
Analytical Metrics
>96% Coverage at 20x Depth
Why Choose a Precision Genomics Approach
High-Quality Sequencing
Advanced clinical-grade Next-Generation Sequencing pipelines.
Fast Turnaround
Actionable risk findings delivered securely within days.
Comprehensive Coverage
Complete analysis spanning 174 core cardiovascular genes.
Clinical Collaboration
Dedicated, provider-focused diagnostic reporting support.
Frequently Asked Questions
Built for Advanced
Cardiovascular Care
Vdiagnostics provides cardiologists and clinical teams with complete operational support, making genetic ordering and risk stratification completely frictionless.
Provider ordering dashboard
Instant requisition submission.
Genetic interpretation reports
Deductive decision guidelines.
Family cascade tracking
Visual pathway index for kin.
Risk stratification system
Gene-to-phenotype profiling.
Long-term patient monitoring
Dynamic surveillance mapping.
Transform Cardiovascular Care
Through Genetic Intelligence
Move from reactive cardiology to predictive precision medicine by understanding inherited cardiovascular risk at the genomic level.